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Paper
Brain network reorganisation and spatial
lesion distribution in systemic lupus
erythematosus
Maria del C Valdes Hernández1,2, Keith Smith3,4,
Mark E Bastin1, E. Nicole Amft5, Stuart H Ralston6,
Joanna M Wardlaw1,2 and Stewart J Wiseman1,2
Abstract
Objective: This work investigates network organisation of brain structural connectivity in systemic lupus erythema-
tosus (SLE) relative to healthy controls and its putative association with lesion distribution and disease indicators.
Methods: White matter hyperintensity (WMH) segmentation and connectomics were performed in 47 patients with
SLE and 47 healthy age-matched controls from structural and diffusion MRI data. Network nodes were divided into
hierarchical tiers based on numbers of connections. Results were compared between patients and controls to assess for
differences in brain network organisation. Voxel-based analyses of the spatial distribution of WMH in relation to
network measures and SLE disease indicators were conducted.
Results: Despite inter-individual differences in brain network organization observed across the study sample, the con-
nectome networks of SLE patients had larger proportion of connections in the peripheral nodes. SLE patients had statis-
tically larger numbers of links in their networks with generally larger fractional anisotropy weights (i.e. a measure of white
matter integrity) and less tendency to aggregate than those of healthy controls. The voxels exhibiting connectomic differ-
ences were coincident with WMH clusters, particularly the left hemisphere’s intersection between the anterior limb of the
internal and external capsules. Moreover, these voxels also associated more strongly with disease indicators.
Conclusion: Our results indicate network differences reflective of compensatory reorganization of the neural circuits,
reflecting adaptive or extended neuroplasticity in SLE.
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Key messages
• Brain network organisation in SLE patients and
healthy age-matched controls significantly differ in
some regions.
• SLE showed greater complexity of connectivity pat-
terns in hub regions.
• SLE patients had more network links with larger
fractional anisotropy weights than healthy controls.
• Network differences relate to clusters where brain
lesions are more strongly associated with disease
indicators.
Introduction
The human autoimmune disease systemic lupus erythe-
matosus (SLE) affects multiple organ systems,
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including the brain. Patients commonly experience
fatigue,1 overt cognitive symptoms and impaired endo-
thelial function,2 while the risk of stroke is higher than
that of the general population.3,4 Cerebral small vessel
disease (SVD) has been reported in SLE, but was not
associated with SLE disease activity, disease duration
nor blood markers of inflammation and endothelial
function in a prior analysis of 47 patients that investi-
gated SVD across global brain networks.5 The main
signature of SVD is the presence of white matter hyper-
intensities (WMH) on structural brain MRI scans.
WMH can be commonly found in the brains of older
adults with or without clinical symptoms.6 They are
negatively associated with cognition,7 and increased
risk of stroke and dementia,8 and are also seen in
SLE.5 Whether their distribution relates to disease indi-
cators and to specific neuroanatomical signatures dif-
ferent from normal healthy individuals is not known.
Connectomics9,10 uses graph theory11 to analyse the
structural (white matter) and functional (correlated
brain activity) brain networks derived from MRI tech-
niques. Previous work that used connectomics in SLE
found global network measures related to cognitive
abilities and clinical systemic damage, but not active
disease.12 Another study found that brain connectivity
networks in SLE patients had decreased efficiency and
increased characteristic path length compared to
healthy controls.13 Complementary to the previously
mentioned study,12 regional network degree and
nodal efficiency in frontal, occipital and cingulum
regions negatively correlated with disease activity in
this smaller SLE cohort.13 Another study also found
abnormal global efficiency and network path length in
SLE patients compared to controls despite similar
functional hub connectivity measurements.14
A new paradigm for understanding the complex net-
work topology of the brain has recently been proposed
in which hierarchically equivalent nodes have variable
connectivity patterns.15 The fact that the brain’s
numerous regions with different functional specialisa-
tions necessitate a wide variety of connectivity patterns
in the supporting structure constitutes the basis of this
paradigm. Once global connectivity patterns are
assessed, it explores the different degree strengths and
hubs in the network. Smith et al.15 demonstrated that
in healthy adults, dividing the connectome into four
tiers based on connectivity degree, the most complex
nodes were found in the middle two tiers. This sug-
gested that hierarchical complexity of the human
adult connectome is not driven by hub nodes, but
rather by nodes mainly in heteromodal integrative
regions and to a lesser but still significant extent in
more basic sensorimotor and visual-semantic areas.
Since SLE pathophysiology is not related to abnor-
mal brain architecture, hierarchically complex
connectivity patterns similar to those present in healthy
individuals should exist in SLE. However, to the best of
our knowledge there has not been a study on the hier-
archical structure of the connectome in SLE patients.
Moreover, it is not known if they differ from those of
disease-free individuals as a destructive by-product of
the disease or are ‘reorganised’ as a compensatory
mechanism; for example, to re-route signals between
regions to circumvent strategically located WMH.
Diffusion tensor magnetic resonance imaging (DT-
MRI) tractography studies have shown that, in SLE
patients, mean diffusivity —a biomarker of brain
white matter integrity— is significantly higher than in
age-matched controls16 and specifically altered in the
corpus callosum, uncinate tracts, thalami and cingu-
la.17–20 These findings suggest possible diffuse whole-
brain damage represented by the prevalent presence of
WMH in these regions. Moreover, another DT-MRI
study showed that white matter microstructure in SLE
patients is related to disease duration and fatigue.21 To
progress our understanding of how SLE affects the
brain, it is useful to investigate the organisation of
brain network connections in relation to underlying
disease characteristics, and how the specific spatial
location of WMH might also map to hierarchical
tiers and function. Such knowledge could lead to
useful connectomic biomarkers of SLE disease
pathophysiology.
Here, we seek to 1) understand if brain network
organisation in SLE differs from controls and if so,
2) to explore whether the differences between networks
in SLE patients relate to lesion load and 3) investigate
whether the lesion load distribution in SLE patients is
related to SLE disease markers.
Methods
Subjects
We retrospectively analysed data from a study on SLE
and age-matched healthy adults recruited by advertise-
ment from staff working at the University of
Edinburgh, the Western General Hospital and the
Royal Infirmary, Edinburgh, United Kingdom. SLE
patients were examined by a consultant rheumatologist
at a specialist SLE clinic between April and December
2014. From the 51 SLE patients who participated in the
primary study that provided data for the present
study,5 we analysed data from the 47 patients that
had available connectome data. All patients met the
updated American College of Rheumatology 1997 cri-
teria for SLE.22 The South East Scotland Research
Ethics Committee gave study approval (01, 14/SS/
0003). The healthy adults from our control group
were recruited to participate in a study approved by
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the Lothian Research Ethics Committee (REC 05/
S1104/45). All participants gave written consent.
Disease indicators
Current SLE disease activity was assessed using the
Systemic Lupus Erythematosus Disease Activity
Index 2000.23 Increasing level of anti-double-stranded
DNA from blood samples was also considered an indi-
cator of disease activity. Accumulated permanent
damage from SLE was assessed with the Systemic
Lupus International Collaborating Clinics
(SLICC)24,25 damage index and disease duration.
Indicators of endothelial function extracted from SLE
patients’ blood samples included von Willebrand
Factor (VWF) antigen and homocysteine. We also
used the following vascular risk factors: presence vs.
absence of hypertension and smoking status from the
patients’ medical history, and measures of total choles-
terol, homocysteine and anticardiolipin IgG and IgM
obtained from the analyses of the blood samples.5
Fatigue was assessed using the Fatigue Severity Scale,
and fibrinolysis was assessed through D-dimer presence
in blood.
MRI acquisition
All MRI data were acquired using a GE Signa Horizon
HDxt 1.5 T scanner (General Electric, Milwaukee, WI,
USA) using a self-shielding gradient set with maximum
gradient strength of 33mTm1 and an 8-channel
phased-array head coil. The scan protocols included
axial T2-, gradient-recalled echo-, fluid-attenuated
inversion recovery-, sagittal T2- and high-resolution
coronal 3D T1-weighted volume sequences, and a
whole brain DT-MRI acquisition. The DT-MRI pro-
tocol from both studies consisted of three T2-weighted
and 32 diffusion-weighted (b¼ 1000 smm2) axial
single-shot spin-echo echo-planar (EP) imaging vol-
umes (field of view 240 240mm, matrix 128 128,
TR 13.75 s, TE 78.4ms).5 Scanning protocol parame-
ters are detailed in Supplementary Table 1 of the
Supplementary Material.
Image processing
Each 3D T1-weighted volume was parcellated into 85
regions-of-interest (ROI), consisting of 68 cortical (34
per hemisphere) and 16 sub-cortical (eight per hemi-
sphere) regions, plus the brainstem, using the
Desikan-Killiany atlas in FreeSurfer (http://surfer.
nmr.mgh.harvard.edu).26 The results were used to con-
struct the tissue and region-of-interest (ROI) masks for
network construction and to constrain the tractogra-
phy output. WMH and intracranial volume (ICV) were
extracted semi-automatically using the MCMxxxVI
Lesion Extraction tool (www.sourceforge.net/projects/
bric1936), followed by a thorough manual boundary
rectification if/where needed, as described in Valdes-
Hernandez et al.27 Diffusion data were processed
using the FMRIB Diffusion Toolbox (FDT) package
in FSL.28 From it, the BedpostX/ProbTrackX algo-
rithm28 was used to perform whole-brain probabilistic
tractography. The mean fractional anisotropy (FA)
values obtained were used to construct the brain net-
works. As network nodes were not found at the left and
right ventral diencephalon (i.e. hypothalamus), net-
work construction was based on 83/85 ROIs. Details
on these procedures and on network construction29,30
can be found in the Supplementary Material.
Network analysis
Two levels of analysis (firstly global then hierarchical
tier-based) were implemented to understand character-
istics of the connectomes and possible relationships
between the two.
We chose three global network metrics based on
their suitability and known relevance to the human
structural connectome. The number of links relative
to the number of nodes in the network is a widely stud-
ied property31 which can be characterised by the nor-
malised network density and average degree. Globally
we compute network density for the unthresholded net-
works, since network density is fixed by the threshold
and so would not differ from participant to participant.
The global clustering coefficient assesses the tendency
of neighbouring nodes to connect to the same other
neighbours. This concept of homophily has been
shown to be a particularly evident trait of structural
connectomes.32 We also computed the hierarchical
complexity, to measure the extent of topological/func-
tional diversity across the degree hierarchy of the
connectomes.15,33
Based on the findings of consistent hierarchical tiers
across structural connectomes, we also conducted
within-tier network analyses. Following Smith
et al.,15 each structural connectome was split into
four tiers based on quartiles of the maximum degree.
Tier 1 consisted of all nodes with degree greater than
75% of the maximum degree, Tier 2 of all nodes with
degree greater than 50% and up to 75% of the maxi-
mum degree, and so on.
We used three metrics to assess tier network topol-
ogy to correspond to those chosen for global analysis.
Thus, in each study participant, the average degree of
nodes in each tier was computed to track any consistent
differences in the number of links established. Unlike
for the global measure of density, this is free to vary
within tiers in the thresholded networks. The average
local clustering coefficient was computed to assess
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average levels of homophily in the tiers. Finally, hier-
archical complexity was computed within each tier to
assess the level of within-tier topological diversity.
Network-lesion spatial distribution analysis
To investigate the spatial relationship between network
topology and lesions in relation to disease indicators in
SLE patients, we conducted two analyses.
The first analysis consisted of comparing the lesion
distribution in the patients’ network tiers with the
lesion distribution in the regions that correspond to
the control group’s network tiers, mapped to each
SLE patient’s brain (see Supplementary Figure 1).
For this, we mapped the tiers in each control subject
into an age-relevant (55 years old, as this reflects the
age of our cohort) template34 (https://datashare.is.ed.
ac.uk/handle/10283/1957), hereafter called the ‘study
template’, using non-linear registration, via
NiftyReg35 (http://sourceforge.net/projects/niftyreg/)
through TractoR (http://www.tractor-mri.org.uk/diffu
sion-processing). As a result of this process we
obtained a probability distribution map of each tier
in the control group which we named “control tiers”.
Next, using the same software, we applied non-linear
registration to map the “control tiers” to the native
space of each SLE patient’s brain and calculated, for
each patient, the percentage of WMH and “normal-
appearing” grey matter in each mapped tier.
The second analysis consisted of investigating the
brain locations where the presence of WMH could be
associated with disease indicators and network topolo-
gy in SLE patients. For this, we co-registered all
patients’ structural brain images to the study template
using 12-degrees affine registration (as per Dickie
et al.34 and Valdes Hernández et al.,36 specifically for
the case of inter-subject co-alignment of periventricular
and deep brain lesions), using the same software tools
mentioned above, and applied the space transforma-
tion to the WMH binary masks. Then, we generated
a) spatial probability maps of WMH for each patient
subgroup (e.g. hypertensive/normotensive patients,
patients with high/low cholesterol, etc.) and b) a 4D
volume of all WMH maps concatenated. Patient sub-
groups were determined by dichotomising and separat-
ing into quartiles the disease indicators listed in the
subsection “Disease indicators” above. The threshold
used to dichotomise the continuous variables was the
median value in the SLE sample.
Repeatability analysis
We evaluated whether the pattern of similarities/dis-
similarities between tiers’ structure of SLE patients
and controls could be replicated if the control group
included more subjects, and if the “control tiers” were
generated using a different criterion. This analysis and
its results are explained in the Supplementary Material.
Statistical analysis
We performed three analyses, using MATLAB 2017 b
and SPSS Statistics 21. The first analysis aimed to
determine whether the connectome networks differed
between SLE and control groups. The second analysis
consisted in exploring whether differences between con-
trols’ and patients’ brain networks were spatially relat-
ed to the lesion load distribution in the SLE group. The
third analysis consisted in exploring where the lesion
load distribution in SLE patients was related to SLE
disease markers and whether this voxel-wise associa-
tion could be explained by the connectome network
characteristics in this group.
For the first analysis we used the Wilcoxon rank
sum tests on network metrics between SLE patients
and healthy controls. The Benjamini-Hochberg false-
detection rate procedure37 was implemented afterwards
across the entire set of resulting p-values with the strict
criteria of q¼ 0.05. For each tier, we also calculated the
Pearson’s correlation coefficients between groups of
the number of times individual ROIs were designated
to that tier.
For the second analysis we compared the percentage
of WMH volume in the regions that corresponded to
each “control” tier in the patient native space with the
percentage of WMH volume in the corresponding
patient tier using the Wilcoxon matched-pair signed-
rank test. Of note, for these comparisons the WMH
volume in each tier was adjusted by the tier volume.
We also calculated the bootstrapped Pearson’s correla-
tion coefficient between these values using n¼ 1000
samples. Similarly, we evaluated volumetric differences
between the “normal-appearing” tissue in these regions
by comparing the percentage of “normal-appearing”
grey matter volume in each “control” tier in the patient’s
image space with the percentage of “normal-appearing”
grey matter volume in the patient’s own tier.
For the third analysis, we performed voxel-based
statistical comparisons of WMH maps using the
Wilcoxon’s rank sum test (i.e. to compare two opposite
patient groups: e.g. normotensive vs. hypertensive
patients, patients with high cholesterol vs. those with
low cholesterol, etc.), and the Kruskal-Wallis test (i.e.
to compare the WMH maps from more than two
groups, e.g. patients falling in each quartile of the
vWF antigen). Voxel-wise false discovery rate was
used to correct for multiple comparisons. We also
implemented a voxel-wise regression model using the
4D WMH volume constructed as previously explained
and a machine-learning approach. This used the
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MATLAB function “fitrlinear” to fit a regularised
Support Vector Machine regression model with a
ridge penalty type optimised through a stochastic gra-
dient descent approach for accuracy. This model was
selected due to the high-dimensionality and sparsity of
the predictor data. In these regression models our pre-
dictor was the probability distribution map of WMH in
the sample, the covariates were age and biological sex
and the outcome was the disease indicator or the net-
work global measure. Also, to reduce sparsity, each of
the 3DWMH arrays (i.e. these 3D arrays from the 4D
array used in the models) were resized to the 3D space
limited by the bounding box of the intracranial volume
of the study brain template. The regularisation term
strength was set at 1/47.
Data availability statement
MRI and associated meta-data from the healthy con-
trol sample are available from the Brain Images of
Normal Subjects (BRAINS) Imagebank (https://www.
brainsimagebank.ac.uk/) (Job et al.38) Specifically, the
primary study that provided these data is labelled as
NIH-DTI39 in the Study Provenance Information of
this database, available from (https://www.brainsimage
bank.ac.uk/datasets) (accessed on 21.10.2019). Brain
templates, probability distribution maps, brain net-
work connectivity metrics (global and per tiers) from
both patients and controls, and software associated to
this publication are all freely available from Edinburgh
Datashare (https://datashare.is.ed.ac.uk/handle/10283/
3515).40 The SLE clinical and imaging data are not
publicly available as they contain information that
could compromise the privacy of research participants.
Results
Subjects
Forty-seven SLE patients of mean age 48.5 (SD 13.7)
years had connectome data (Table 1). Less than one-
fifth (17%) were hypertensive, none had diabetes,
12.7% were current smokers, and one subject had a
history of stroke. Four patients were left-handed and
none had neuropsychiatric symptoms. The control
group had 47 healthy adults of similar age to the
patient group.
First analysis: Comparison between the SLE patient
group and control group connectome networks
Brain connectivity. Average weights and number of links
were both found to have statistically significantly
higher values in SLE patients (p ¼ 9:95 107;
Cohen’s d¼ 0.9818 and p ¼ 1:51 107; Cohen’s
d¼ 1.0880, respectively) than in controls.
Global and hierarchical structural network topology. The
spatial distribution of the tiers for SLE patients and
controls is shown in Figure 1. More details can be
found in Supplementary Table 2, complemented by
Supplementary Figure 3.
Despite variation in tier distribution in SLE patients
and controls (Figure 1, Supplementary Table 2 and
Supplementary Figure 4) there was high correlation
of the FreeSurfer ROI (i.e. network nodes) placements
within tiers between the two groups: r¼ 0.972 for
Tier 1, r¼ 0.986 for Tier 2, r¼ 0.813 for Tier 3 and
r¼ 0.921 for Tier 4 (Supplementary Figure 3). A few
ROIs were inconsistently placed: we observed a tenden-
cy for these ROIs of SLE patients to be represented in
lower order tiers suggesting a loss of importance in the
network hierarchy (see Figure 1 and Supplementary
Table 2).
The histograms showing the distributions for net-
work density (equivalent to average degree for fixed
number of links), clustering coefficient and hierarchical
complexity for SLE patients and controls are plotted in
the left-hand side column of Figure 2. Analysis within
tiers are then plotted in subsequent columns. The p-
values of the Wilcoxon rank sum tests are shown in
the top of each plot with an asterisk (*) indicating
where the value passed the false detection rate
procedure.
The network density was higher in SLE patients
(Cohen’s d¼ 0.6166). The higher average degree in
Tier 4 nodes (Cohen’s d¼ 0.6546) provides an explana-
tion for this. Peripheral SLE nodes have a larger pro-
portion of connections, although there is no sign of a
redistribution of this amongst any of the other tiers as
the average degree in Tiers 1-3 did not significantly
differ between SLE patients and controls.
There was a particularly strong difference in the
clustering coefficient between the two populations.
Clustering was significantly less in SLE than in healthy
controls (Cohen’s d¼ 1.1235). Tier based analysis
showed this difference across tiers (Figure 1), although
the difference did not survive false discovery rate in
Tier 4.
Global hierarchical complexity was not found to be
different between the populations. Individually, how-
ever, the complexity of Tier 1 was significantly
increased in SLE patients (Cohen’s d¼ 0.5281).
Complexity in other tiers did not differ.
Second analysis: Analysis of the spatial relationship
between lesion load and network topology in the
SLE group
Spatial lesion distribution per tiers. The spatial distribution
of the tiers in the SLE patients is detailed in
Supplementary Table 2. Given that these refer to
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network node locations, which are in the cortical and
deep grey matter, whereas WMH are mainly in the
white matter, the percentage of WMH in the tiers is
small compared to the overall WMH volume: median
0.0615% in ICV [0.0323 0.150]. Table 2 shows the
WMH load per tier. Tier 1 has the highest percentage
of WMH burden across the sample (mean 1.945% of
Tier 1 volume, SD 3.332%). Tier 1 mainly covers the
Table 1. Groups characteristics.
SLE patients Healthy controls
Demographics
N 47 47
Age, years (SD) 48.5 13.7 44.6 11.5
Female 43/47 (91.5%) 41/47 (87.2%)
Steroids 17/47 (36%) Not applicable
Disease activity
SLEDAI (Q1 to Q3) 2 (0 to 4) Not applicable
Anti-double-stranded DNA (Q1 to Q3) 14.9 (8.67 to 29.12) Not applicable
Permanent damage
Disease duration, months (Q1 to Q3) 49 (24 to 118) Not applicable
SLICC (Q1 to Q3) 0 (0 to 1) Not applicable
Endothelial function
Von Willebrand Factor antigen (Q1 to Q3) 1.52 (1.27 to 1.85) Not applicable
Homocysteine (Q1 to Q3) 17 (15 to 20) Not applicable
Vascular risk factors
Hypertension (Y/N) 8/47 (17%) Not applicable
Smoking status 27/47 (57.4%) never,
14/47 (29.8%) previous,
6/47 (12.8%) current smokers
Not applicable
Total cholesterol (Q1 to Q3) 4.9 (4.4 to 5.5) Not applicable
IgG (Q1 to Q3) 2.95 (1.98 to 5.32) Not applicable
IgM (Q1 to Q3) 1.65 (1.12 to 3.22) Not applicable
Fatigue
Fatigue Scale Scores (Q1 to Q3) 5.5 (4.26 to 6.26) Not applicable
Fibrinolysis
D-dimer (Q1 to Q3) 112.5 (69.75 to 172.5) Not applicable
White matter hyperintensities (WMH)
Volume (ml) 0.83 (0.017 to 26.667) Negligible
Global network connectivity measures
Mean weight 0.4153 (0.0156) 0.3961 (0.0185)
Density (%) 40.97 (3.01) 36.77 (3.47)
At 25% density
Clustering coefficient 0.4602 (0.0305) 0.4949 (0.0197)
Normalised degree variance 0.2879 (0.0240) 0.3050 (0.0290)
Hierarchical complexity 0.4281 (0.1615) 0.3934 (0.1598)
Tier-based network connectivity measures
Tier 1 average degree 46.82 4.20 45.83 2.51
Tier 2 average degree 32.40 2.61 32.11 2.14
Tier 3 average degree 19.68 1.27 19.50 1.47
Tier 4 average degree 6.75 0.80 6.18 0.86
Tier 1 clustering coefficient 0.3984 0.0377 0.4251 0.0253
Tier 2 clustering coefficient 0.4726 0.0420 0.5208 0.0330
Tier 3 clustering coefficient 0.5397 0.0490 0.5920 0.0389
Tier 4 clustering coefficient 0.4202 0.0797 0.4541 0.0804
Tier 1 hierarchical complexity 0.0204 0.0054 0.0172 0.0061
Tier 2 hierarchical complexity 0.0646 0.0251 0.0598 0.0252
Tier 3 hierarchical complexity 0.1964 0.0723 0.1805 0.0534
Tier 4 hierarchical complexity 0.8411 0.3619 0.7916 0.3471
Values are mean, median (Q1 to Q3), or number (%). SLE¼ systemic lupus erythematosus, SLEDAI¼ Systemic Lupus Erythematosus Disease Activity
Index, SLICC¼ Systemic Lupus International Collaborating Clinincs.
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thalami, precuneus, left putamen and left globus pal-
lidus. In 30–60% of the patients it also extends to the
right putamen and right globus pallidus. The second
highest percentage of WMH burden in this sample is
in Tier 2 (mean 1.198% of Tier 2 volume, SD 2.054%).
This tier is more widely distributed, but in 10–50% of
patients it shares the caudate, putamen, globus pallidus
and in 45% of patients it includes the brainstem. Tier 3
shares the smallest percentage of WMH burden in the
sample (mean 0.718% of Tier 3 volume, SD 1.260%),
in the caudate and brainstem. When the control tiers
were mapped into the patients’ brain, the distribution
of WMH load per tier followed a similar pattern: Tier 1
had most of the WMH followed by Tier 2, and Tier 3
the fewest. However, their share significantly differed
(Table 2). The load of WMH in each mapped tier was
significantly correlated despite lack of correlation
between some of the apparently healthy grey matter
(GM) volumes in each mapped tier (Supplementary
Table 3).
Figure 1. Connectome nodes in controls and SLE patients organized into hierarchical tiers. The expected tier structure is given for
left and right regions of interest excluding the brainstem. Diagram confirms large correspondence between controls and SLE patients.
However, some nodes in SLE patients are re-organized in the network hierarchy with a tendency for nodes to shift from more
important tiers to lower in the tier structure (example: the tier 1 nodes right pallidum and left superior parietal gyrus are placed in
tier 2 in SLE, as indicated by the down arrows). Compensatory re-structuring sees some nodes in SLE patients go in the opposite
direction, that is, to higher orders in the hierarchy (example: the right inferior temporal gyrus (a tier 3 node) is a tier 2 node in the SLE
cohort, as indicated by the up arrow). Four right side tier 3 nodes are noted to “shift down” to lower order tier 4 nodes in SLE. Tier 1
is represented in red, Tier 2 in blue, Tier 3 in green and Tier 4 in purple.
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Third analysis: Voxel-based associations between
white matter hyperintensities, network measures
and clinical indicators in the SLE group
Spatial lesion distribution in patient groups with differing levels
of disease burden. WMH spatial distribution differed in
patients with different levels of disease burden, mainly
in the periventricular regions, especially in the anterior
horns of the lateral ventricles, and in small clusters in
the deep white matter. Supplementary Figures 5 to 9
show some examples, but full volume maps in nifti-1
format are available for all variables evaluated (see
data availability statement). Patients with more
advanced and active disease, endothelial dysfunction
(i.e. von Willebrand Factor Antigen), fatigue and pres-
ence/high values of vascular risk factors had more
WMH towards the deep white matter and optical radi-
ation, compared to those in early disease stages and
with absence/low values of vascular risk factors who
had the WMH distributed similar to a large non-
dense cloud in the periventricular regions. In general,
these differences were statistically significant only in
periventricular clusters. But for vascular risk factors
(e.g. total cholesterol, Supplementary Figure 7 and
hypertension, Supplementary Figure 8) statistically sig-
nificant differences were additionally observed in deep
white matter regions. After applying false discovery
rate, voxel-wise differences between WMH in patients
with high vs. low values of the Fatigue Scale Score and
long vs. short disease duration disappeared.
Voxel-based regression analysis. Spatial associations
between WMH, all network measures and disease indi-
cators were found after adjusting for age and biological
sex. Figure 3 shows representative slices of the study
template with the voxels that resulted in positive
(green) and negative (red) associations, with the
colour intensity being proportional to the strength of
the associations. Supplementary Table 4 shows the
non-standardised B values of the clusters with the max-
imum and minimum associations, as well as the median
and interquartile range values of these associations in
the rest of the voxels where associations were signifi-
cant. The strongest associations of WMH clusters were
observed with clinical parameters extracted from the
blood samples (Supplementary Table 4).
In all cases, the most relevant negative associations
(i.e. in terms of voxel-wise strength and aggregated
volume) were found in the periventricular regions of
the antero-inferior borders and anterior horns of the
lateral ventricles. Although positive associations were
found in small clusters scattered throughout the brain,
wide clusters located in regions of coalescence between
periventricular and deep WMH and in temporo-
parietal regions showed stronger associations between
WMH and markers of clinical disease severity (SLICC
and lupus duration) and vascular risk factors (smoking
status, hypertension (y/n), homocysteine, total choles-
terol and anticardiolipin IgG and IgM). Interestingly,
WMH in the brainstem strongly associated with vascu-
lar risk factors, but not with clinical disease
Figure 2. Histograms of network metrics of SLE structural connectomes (orange) and healthy controls (blue). The first left-hand side
column shows global metric values and subsequent columns show tier metric values. The first plot in the top row shows the global
network density, d, from the unthresholded networks, since global average degree is fixed by the threshold. Average degree, <k>, is
shown subsequently in the other columns of the top row for individual tiers. The second row shows global and tier-specific clustering
coefficent, C, and the third row shows global and tier-specific hierarchical complexity, R.
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Figure 3. Illustration of the voxel-based association between WMH and: (a) measures of active disease (SLEDAI and anti-double-
stranded DNA), (b) endothelial function indicators (von Willebrand factor antigen and homocysteine), (c) measures of clinical disease
“damage” (SLICCþ Lupus duration), and (d) vascular risk factors (smoker, hypertension (y/n), homocysteine, total cholesterol,
anticardiolipin IgG and IgM). From left to right: representative coronal, sagittal and axial slices (above) and five axial slices (below)
showing the brain voxels of the study template where positive (red) and negative (yellow) associations were found. The colour
intensity is proportional to the strength of the association (normalised to absolute values between 0-maximum B-value for visual
representation).
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manifestations, endothelial dysfunction or measure-
ments of active disease (SLEDAI and anti-
double-stranded DNA). WMH in a cluster located in
the intersection between the anterior limb of the inter-
nal and external capsules in the left hemisphere’s cor-
ticopontine white matter tract had stronger negative
association with hypertension, total cholesterol, homo-
cysteine and anticardiolipin IgG and IgM and with
markers of clinical disease than in the rest of the loca-
tions where associations were found. However, when
we added the effect of smoking status (i.e. which ranges
from 0: non-smoker to 2: current smoker), the associ-
ation between the total burden of vascular risk factors
and WMH in this cluster became positive (e.g. see
yellow cluster in the location referred above in Figure
3(d)). In the same cluster, WMH were positively asso-
ciated with the connectome network density, and neg-
atively associated with the clustering coefficient, and
hierarchical complexity (Figure 4). In the mirror
region at the right hemisphere, WMH and network
parameters were weakly associated in smaller clusters,
and the direction of the association was the same as in
the left hemisphere.
From all the disease indicators evaluated, D-dimer
(Supplementary Table 4 and Supplementary Figure 10)
had the strongest association with small WMH clus-
ters, localised in the right hippocampus and right pre-
central gyrus, in addition to the relevant regions
previously mentioned where WMH was more strongly
associated with other disease indicators. Smaller clus-
ters in the supramarginal gyrus right, and the pars
opercularis and triangularis of the inferior frontal
gyrus were also found of relevance. Interestingly,
these regions experienced a “shift down” in the
number of connections of the network nodes of the
SLE patients compared to controls (see Figure 1 and
Supplementary Table 2).
Discussion
Despite inter-individual differences in brain network
organization observed across the study sample, the
connectome networks of SLE patients and healthy
age-matched controls significantly differed in some
regions (i.e., pallidum, superior parietal gyri, caudate,
precentral gyrus, cingulate, middle and inferior tempo-
ral gyri, lateral occipital cortex, temporal pole, amyg-
dala, lingual, supramarginal and medial orbitofrontal
gyri, pericalcarine cortex and inferior frontal pars oper-
cularis). SLE patients had statistically larger numbers
of links in their networks with generally higher FA
weights (i.e., potentially increased white matter tract
microstructural integrity) than those of healthy con-
trols. In locations with crossing white matter tracts
(i.e., expected low FA values since no preferred diffu-
sion directionality), this result may reflect axonal
damage in one of the fiber populations, with conse-
quent stronger diffusion along the remaining white
matter fiber bundle, resulting in an apparent increase
in FA despite the tissue being not healthy. The voxels
exhibiting connectomic differences were coincident
with WMH clusters, particularly the left hemisphere’s
intersection between the anterior limb of the internal
and external capsules. Moreover, these voxels also
associated more strongly with disease indicators.
In patients’ brain networks, attempts to bridge ROIs
after lesion damage show larger numbers of connec-
tions with higher FA (i.e., potentially higher density
of coherently ordered myelinated white matter fibers)
which are more randomly distributed (i.e., decrease in
clustering coefficient) and with greater prevalence
in peripheral nodes (i.e., increase in average degree in
Tier 4). These re-routings require a greater complexity
in the hub node connectivity patterns (i.e. increase in
complexity in Tier 1: the tier where the network nodes
Table 2. SLE patients’ white matter hyperintensity (WMH) load A) by tiers, B) by the regions that correspond to the control tiers
and C) by the regions that correspond to the tiers of a wider control group described in Smith et al.15 (see repeatability analysis in the
Supplementary Material). The mean lesion load in each region is given as percentage of lesion volume in the region (e.g. WMH volume
x 100/region volume).
SLE patients WMH
load by tiers (A)
SLE patients WMH
load in ROIs
corresponding to
the control tiers (B)
Related samples
Wilcoxon Signed
Rank test
(between A and B)
(p-value)
SLE patients WMH
load in ROIs of
Smith et al.13
repeatability
control group (C)
Related samples
Wilcoxon Signed
rank test
(between A
and C) (p-value)
Tier 1 1.945 3.332 3.970 4.803 <0.0001 0.318 0.829 <0.0001
Tier 2 1.198 2.054 2.726 4.769 <0.0001 0.253 0.638 <0.0001
Tier 3 0.718 1.260 1.833 3.904 <0.0001 0.222 0.686 <0.0001
Tier 4 0.775 1.958 2.356 4.617 <0.0001 0.820 2.391 0.008
NA region* 0.661 1.304
Note: *The NA (i.e. not-assigned) region extends through 22/83 of the Desikan-Killiany Atlas ROIs. In these ROIs, tiers were inconsistent for the
sample used in Smith et al.,15 in less than 1/3 of the subjects. SLE¼ systemic lupus erythematosus, WMH¼white matter hyperintensity.
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have most connections) at the expense of a decrease in
the nodes’ clustering, precisely due to the higher pro-
portion of lesion load in this region (e.g. native and
control-mapped Tier 1 had the highest percentage of
lesion load). This decrease in Tier 1’s clustering (i.e.,
with respect to the healthy controls) may also indicate
that either the more redundant connections are
dropped or neglected in preference of more variable
neighbour-to-neighbour connectivity patterns, favour-
ing the reorganization of hub connections which create
more variable connectivity patterns in SLE patients.
Smith and colleagues15 analysed a larger sample of
healthy controls using the same graph-theory-based
paradigm and found that Tier 1 nodes were contribut-
ing least in the complexity of the connectomes. When
the control tiers of such sample were mapped in our
patient group, part of the patients’ Tier 1 region was
coincident with the region that exhibited great variabil-
ity amongst this wider control sample, referred to in
this study as “NA region”, which exhibited the highest
proportion of lesion load. We conjecture that the lack
of complexity in healthy Tier 1 hub regions is due to a
more ordered core connectivity structure, providing a
stable platform to integrate the numerous functionally
specialized regions in lower tiers.41 The fact that com-
plexity is increased in SLE patients in Tier 1 would
indicate that this stable structure is undermined by
the disease.
Our results are in-line with those from studies in
other diseases. For example, in Parkinson’s disease
FA has been found increased in the motor tracts42
and selectively decreased in the putamen.43 Neural con-
nectivity reorganization after stroke have seen different
patterns emerging depending on the time from the
stroke event and the extent and location of the
stroke,44 with specific white matter pathways having
greater impact on clinical and functional outcome
regardless of the lesion size.36 Age, atrophy and inflam-
mation are acknowledged to contribute to network
reorganization.45,46 However, the pattern of tract-
lesion interaction and the influence of white matter dis-
ease in this phenomenon are still not very clear.
A study in 52 normal individuals at the beginning of
the 8th decade of life observed that despite WMH
having similar effects on tract infrastructure, whether
they be intersecting or nearby, differences in tract water
diffusion properties around WMH suggest that tract
degeneration may propagate along the white matter
tract for intersecting WMH, while in some areas of
the brain there is a larger and more localized accumu-
lation of axonal damage in tract tissue nearby a non-
connected WMH.47 This study also complements find-
ings by other studies in smaller SLE samples, which
found altered structural network parameters in SLE
patients13,14 compared to controls, with only few differ-
ences in functional hub measures.14
WMH were more strongly associated with disease
indicators and with all the global network measures
in certain clusters distributed across the longitudinal
white matter tracts (i.e. cingulum, arcuate, uncinated
Figure 4. Illustration of the voxel-based associations between WMH and each of the network measures in a representative slice of
each plane. The positive (magenta) and negative (cyan) associations are shown mapped on the study template. The colour intensity is
proportional to the strength of the association (normalised to values between 0–256 for visual representation).
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and inferior longitudinal fasciculi) and their neighbour-
ing structures. All our regression models, which
accounted for age and biological sex, consistently
showed associations in these same locations. This
may indicate that specific brain locations might be
more vulnerable to the presence of WMH and influence
brain network topology. From all the disease indicators
evaluated, the marker of fibrinolysis had the strongest
associations with the same localized clusters of WMH
that were associated with the network measures, possi-
bly suggesting a predominant vascular contribution
underpinning the brain network differences between
patients and controls.
A previous study on global network connectivity
measures and cognition in SLE failed to find a relation
between structural network connectivity and disease
activity12 whilst another found a correlation between
some regional network properties and disease activity
in frontal, occipital and cingulum regions in a sample
half the size of the former.13 Our voxel-based analyses
showed locations where all global network measures
and disease indicators, including disease activity, were
associated with brain lesions in this patient group, and
where connectivity patterns differed from those in a
control population. These locations were coincident
with those found by another study in SLE had an asso-
ciation between disease activity and resting-state func-
tional connectivity.48 Previous results on hierarchical
complexity in EEG functional connectivity30,33 and in
the structural connectome of healthy adults revealed
a topological agreement in complexity between
structure and function, a paradigm that we have cor-
roborated in SLE.
Our study is the first to conduct a voxel-based net-
work topology analysis of the structural human con-
nectome in SLE patients in relation to disease
indicators and lesion distribution and compare the
hierarchical complexity of the brain network in SLE
with that in normal healthy controls. The comparative
analysis of the hierarchical complexity between these
two population groups both globally and by structur-
ally different regions in terms of number of connections
per-node and connectivity patterns, allowed us to
deepen our understanding on the topology and dynam-
ics of these connectivity networks in relation to disease
indicators beyond offering descriptive evidence. We,
for the first time, use a machine-learning approach to
explore the voxel-based associations between brain
lesions, disease indicators and network descriptors.
Our findings, suggestive of compensatory neuroplastic-
ity in SLE, can inform biological models of neurode-
generation and neuroplasticity in SLE and therapeutic
strategies. We used state-of-the-art conventional brain
parcellation and tractography methods proven to gen-
erate accurate results despite imaging protocol
variations. Application of our analysis to larger sam-
ples aiming at extending our machine-learning
approach for its application in precision medicine is
now needed.
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